Adam H. Schechter
2014 - Merck & Co.
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,941,516 |
---|---|
Non-Equity Incentive Plan | $1,432,934 |
Option Awards | $1,262,831 |
Salary | $962,388 |
Stock Awards | $4,623,673 |
Other | $103,994 |
Total | $10,327,336 |
Schechter received $4.6M in stock awards, accounting for 45% of the total pay in 2014.
Schechter also received $1.9M of change in pension value and nonqualified deferred compensation earnings, $1.4M in non-equity incentive plan, $1.3M in option awards, $962.4K in salary and $104K in other compensation.
Rankings
In 2014, Adam H. Schechter's compensation ranked 489th out of 13,032 executives tracked by ExecPay. In other words, Schechter earned more than 96.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 489 | 96th |
Manufacturing | 169 | 97th |
Chemicals And Allied Products | 56 | 97th |
Drugs | 45 | 97th |
Pharmaceutical Preparations | 42 | 96th |
Schechter's colleagues
We found five more compensation records of executives who worked with Adam H. Schechter at Merck & Co. in 2014.
2014
Kenneth Frazier
Merck & Co.
Chief Executive Officer
2014
Robert Davis
Merck & Co.
Chief Financial Officer
2014
Roger Perlmutter
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2014
Bruce Kuhlik
Merck & Co.
General Counsel
2014
Peter Kellogg
Merck & Co.
Chief Financial Officer
News
March 31, 2022
April 2, 2021
April 1, 2020
April 8, 2019